Home Tags Regeneron Pharmaceuticals
Tag: Regeneron Pharmaceuticals
IBM led the way in Westchester, while Charter Communications was the top-ranked firm in Fairfield County.
The Armonk company’s new ranking was reflective of its 4 percent revenue growth in the fourth quarter of 2017, the first increase after 22 consecutive quarters of decline.
The global collaboration partners aim to discover, develop and market new drug treatments in the emerging field of immuno-oncology.
The Food and Drug Administration approves the use of Praluent, developed by Regeneron Pharmaceuticals in Westchester and its French collaborator Sanofi.
The biotech company becomes a Westchester County landowner with its recent purchase of undeveloped property near its Eastview headquarters.
The year-old Regeneron Genetics Center is sequencing genetic samples from a quarter of a million Pennsylvanians as a pioneer of precision medicine.
Acorda Therapeutics posts earnings well above Wall Street expectations, while Regeneron and Progenics also post a profit.
The Greenburgh company has been recognized by Science magazine as the top biopharmaceutical employer in the world for the third year in a row.
Regeneron announces positive study results for a sinus drug, and Progenics' drug Relistor gains another approved use by the U.S. Food and Drug Administration.
Federal officials have designated Regeneron's Eylea drug a breakthrough therapy for diabetic patients with retinal damage.
The Greenburgh-based pharmaceutical company announces its drug alirocumab reduced levels of “bad cholesterol” by 61 percent in a study.
Regeneron Pharmaceuticals and Acorda Therapeutics post gains in earnings compared to the second quarter last year, while Progenics Pharmaceuticals sees a loss.
12Page 1 of 2